Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Clin Pharmacokinet. 2013 Sep;52(9):751–762. doi: 10.1007/s40262-013-0069-2

Table 5.

Significant covariates for the univariate and multivariate analysis.

Significant covariates ΔMOFV P-value
Univariate analysis
Effect of CYP3A5 expressers on CL/F −27.64 < 0.001
Effect of age on CL/F −16.42 < 0.001
Effect of CYP3A4*1B carriers on CL/F −12.95 < 0.001
Effect of MRP2 high activity group on CL/F −11.45 < 0.001
Effect of Caucasian on CL/F −7.24 < 0.01
Effect of diabetes mellitus on lag time −12.96 < 0.001
Multivariate analysis
Effect of CYP3A5 expressers on CL/F +37.02 < 0.001
Effect of MRP2 high activity group on CL/F +10.02 < 0.005
Effect of age on CL/F +22.42 < 0.001
Effect of diabetes mellitus on lag time +25.69 < 0.001

MOFV, minimum objective function value; CYP, cytochrome P450; CL/F, apparent oral clearance; MRP2, multidrug resistance-associated protein 2